Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

New Leukemia Drug Works for Incurable Stomach Tumors, Too


Blanke tells WebMD that Gleevec hones in on c-kit, a gene that sends a signal that tells cells to grow. This gene is present in many cancer cells, he says. If c-kit is abnormal it causes uncontrolled cell growth and multiplication, which forms a tumor. The drug blocks the signal. Oncologist Michael Gordon, MD, of the Arizona Cancer Center in Tucson, says that Gleevec works like a circuit breaker to shut down the power to the cell.

In his study of 139 patients with GIST, more than half of the patients responded to treatment, says Blanke. Hendrickson was patient No. 1.

"They rushed the study because I was so near death," Hendrickson says. "I knew the drug was working right away because in seven days I went from severe pain to moderate pain and after 40 days my first CT scan showed that the tumor was reduced by 47%."

Allan T. van Oosterom, MD, professor of medicine at the University of Leuven in Belgium, says that a smaller study of 36 patients with GIST suggests that the most effective dose is actually 800 mg or twice what Hendrickson takes. "I have two patients who didn't respond at 400 mg; we increased to 800 mg and now they are responding," van Oosterom tells WebMD.

At a press conference Sunday where the Gleevec results were presented at the American Society of Clinical Oncologists meeting held here, he said "I have been waiting 30 years to report results like these."

Although the buzz among the 26,000 cancer specialists attending this meeting is definitely Gleevec, Blanke and van Oosterom both say they are worried that oncologists will try the drug on the wrong patients. The drug is approved for leukemia and "demonstrated efficacy in GIST", but this targeted therapy only works if the target is present. In solid tumors, that means that the tumor must test positive for c-kit and have the mutation that causes overproduction of cells.

Cancer experts worry, too, that patients will demand treatment with the new drug, which has received almost as much publicity about its ease of use as it has about its effectiveness. Unlike other cancer treatments, Gleevec is a pill. Patients should take it after meals, says van Oosterom.

Moreover, the side effects of the drug are minimal. "Sleep disturbances, puffiness around the eyes, a slight rash," says Hendrickson. And the side effects "usually disappear after eight weeks," says van Oosterom.

Blanke says that several other types of cancers express c-kit, and his center is beginning a trial in terminal lung cancer patients while other researchers are testing the drug in pancreatic cancers and brain tumors.

Meanwhile, in Minnesota, Hendrickson celebrated yet another holiday, Mothers' Day, with his wife and three sons. He observed, "I was knocking on death's door until this drug. This stuff is absolutely a miracle."


Today on WebMD

Building a Support System
cancer fighting foods
precancerous lesions slideshow
quit smoking tips
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas